Inogen Inc income statement

In fiscal 2025, Inogen Inc reported revenue of $349m, up 3.9% on the year before, operating income of −$30.2m (a -8.7% margin) and net income of −$22.7m, or −$0.86 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Inogen Inc: income statement, annual
Fiscal year	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Revenue	49	75	113	159	203	249	358	362	308	358	377	316	336	349	354
Cost of revenue	25	36	57	83	106	128	180	190	170	182	224	189	181	194	197
Gross profit	24	39	56	76	97	121	179	172	138	176	154	127	155	154	158
Research and development	2	2	3	4	5	5	7	9	14	17	22	21	22	19	21
Selling and marketing	13	18	24	31	38	51	96	106	98	113	121	107	103	98	98
General and administrative	8	14	18	26	32	38	38	37	39	38	44	75	73	67	69
Operating income	1	4	11	15	23	28	38	20	−12	9	−85	−109	−43	−30	−31
Interest expense	0	1	0	0	0	—	—	—	—	—	—	—	—	—	—
Income before tax	1	4	10	15	23	30	40	24	−5	9	−83	−102	−36	−23	−25
Income tax	0	−22	3	3	2	9	−11	3	1	15	1	0	−1	−1	−1
Net income	1	25	7	12	21	21	52	21	−6	−6	−84	−102	−36	−23	−25
Diluted EPS	−$2.50	$0.68	$0.30	$0.56	$0.97	$0.96	$2.30	$0.94	−$0.27	−$0.28	−$3.67	−$4.42	−$1.52	−$0.86	−$0.91
Diluted shares (average)	2m	2m	18m	21m	21m	22m	23m	22m	22m	22m	23m	23m	24m	27m	27m
EBITDA	6	13	23	29	36	40	49	34	7	31	−62	−91	−22	−10	−14

US$ millions unless shown otherwise. Fiscal quarters.

Inogen Inc: income statement, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Revenue	89	80	82	92	92	82	85	95
Cost of revenue	47	44	46	51	51	46	47	52
Gross profit	41	36	36	41	41	35	38	43
Research and development	4	6	4	5	5	5	5	6
Selling and marketing	26	24	24	25	25	23	25	25
General and administrative	19	18	16	17	18	16	17	18
Operating income	−8	−11	−8	−6	−7	−9	−9	−5
Income before tax	−6	−10	−6	−4	−5	−7	−8	−4
Income tax	−0	−0	−0	−0	−0	−0	−0	−0
Net income	−6	−10	−6	−4	−5	−7	−8	−4
Diluted EPS	−$0.25	−$0.41	−$0.25	−$0.15	−$0.20	−$0.27	−$0.30	−$0.14
EBITDA	−4	−6	−2	−2	−3	−4	−4	−2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: INGN vs TCMD INGN vs STAA INGN vs INMD INGN vs PRCT

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inogen Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inogen Inc.